Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87633 refers to a diagnostic test that detects infectious agents through the analysis of nucleic acids, specifically DNA or RNA, in respiratory specimens. This test is designed to identify a range of respiratory viruses, which may include adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus (RSV), and rhinovirus. The procedure involves collecting a respiratory specimen, which can be obtained through various methods such as bronchoalveolar lavage, nasal wash, nasopharyngeal swab, or pleural fluid aspiration. Once the specimen is collected, it undergoes a sophisticated testing process that utilizes multiplex reverse transcription polymerase chain reaction (RT-PCR). This technique allows for the simultaneous extraction and amplification of DNA or RNA from multiple types or subtypes of respiratory viruses. The amplified nucleic acid fragments are then sized and analyzed to determine the specific viral types or subtypes present in the specimen. This code is specifically applicable when testing for 12 to 25 different targets, providing a comprehensive assessment of potential viral infections in the respiratory tract. For tests involving fewer targets, different codes are utilized: CPT® Code 87631 is used for 3-5 targets, and CPT® Code 87632 is designated for 6-11 targets.
© Copyright 2026 Coding Ahead. All rights reserved.
The CPT® Code 87633 is indicated for use in the detection of specific respiratory viral infections. The following conditions or symptoms may warrant the performance of this test:
The procedure for CPT® Code 87633 involves several key steps to ensure accurate detection of respiratory viruses. The following outlines the procedural steps:
Post-procedure care for patients undergoing testing with CPT® Code 87633 typically involves monitoring for any immediate adverse reactions related to the specimen collection method used. Patients may experience mild discomfort or irritation at the site of specimen collection, particularly with nasopharyngeal swabs. Results from the test are usually available within a specified timeframe, depending on laboratory processing capabilities. Clinicians should follow up with patients to discuss the results and any necessary treatment options based on the identified viral pathogens. Additionally, it is important to consider the implications of the test results for infection control measures, especially in the context of potential outbreaks or in vulnerable patient populations.
| Short Descr | RESP VIRUS 12-25 TARGETS | Medium Descr | IADNA RESPIRATRY PROBE & REV TRNSCR 12-25 TARGET | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | Yes | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GZ | Item or service expected to be denied as not reasonable and necessary | QW | Clia waived test | GA | Waiver of liability statement issued as required by payer policy, individual case | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GW | Service not related to the hospice patient's terminal condition | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service | 77 | Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | CR | Catastrophe/disaster related | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | KX | Requirements specified in the medical policy have been met | Q4 | Service for ordering/referring physician qualifies as a service exemption | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | QP | Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060. | XE | Separate encounter, a service that is distinct because it occurred during a separate encounter |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Changed | Description Changed |
| 2013-01-01 | Added | Added |
Get instant expert-level medical coding assistance.